Showing BioInteractions for Triflusal (DB08814)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
Interacting Group | Interacting Drugs | |
---|---|---|
Triflusal is a Nuclear factor NF-kappa-B p105 subunit antagonist | ||
1 | Nuclear factor NF-kappa-B p105 subunit antagonists | Thalidomide |
2 | Nuclear factor NF-kappa-B p105 subunit inhibitors | Pseudoephedrine |
Interacting Group | Interacting Drugs | |
---|---|---|
Triflusal is a Nitric oxide synthase, inducible agonist | ||
1 | Nitric oxide synthase, inducible negative modulators | Dexamethasone, Dexamethasone acetate |
2 | Nitric oxide synthase, inducible inhibitors | Miconazole, Minocycline, Pimagedine |
3 | Nitric oxide synthase, inducible agonists | Levamlodipine |
4 | Nitric oxide synthase, inducible substrates | Doxorubicin |
5 | Nitric oxide synthase, inducible inducers | Levamlodipine |
6 | Nitric oxide synthase, inducible antagonists | Dipyrithione |
Interacting Group | Interacting Drugs | |
---|---|---|
Triflusal is a cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A antagonist | ||
1 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A inhibitors | Dipyridamole, Papaverine, Tofisopam |